Barry Featherman is Executive Director, Government Affairs, Intercontinental Region and Global Patient Solutions at Gilead Sciences.

Gilead is a biopharmaceutical company that discovers and develops innovative medicines for life-threatening diseases. Gilead makes it a priority to increase access to these medicines for people who can benefit from them, regardless of where they live or their ability to pay.

Prior to Gilead, Mr Featherman was a Principal at Featherman Strategic Advisors and at the Podesta Group where he  advised clients in the Financial Services, Healthcare, IT, Renewable Energy, Defence and Training sectors on international expansions, and assisted clients with conducting business with governments and businesses in Latin America, Europe, Asia, the Middle East, Canada and the United States.